TotalMarketCap

Nuvectis Pharma

NVCTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$610.747 M

$17.76 -3.84%

Close of 6 Nov 2026

As of 6 Nov 2026, Nuvectis Pharma (NVCT) has a market capitalization of $610.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$26.4M

Loss-making

Shares outstanding

34,388,908

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #173Helus PharmaHELP$613.7M
  2. #174GeronGERN$612.0M
  3. #175Nuvectis PharmaNVCT$610.7M
  4. #176Kura OncologyKURA$606.3M
  5. #177ArriVent BioPharmaAVBP$602.5M

What if Nuvectis Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$821,104.11

Per share 46,233× higher

Bitcoin $1.53T

$44,428.51

Per share 2,502× higher

Apple $5.02T

$145,854.66

Per share 8,213× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Nuvectis Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.